{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 AST-GN Ceftazidime/Avibactam"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K172944",
    "Predicate Device Reference 510(k) Number(s)": [
        "K161510"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTW",
        "LTT"
    ],
    "Summary Letter Date": "September 25, 2017",
    "Summary Letter Received Date": "September 26, 2017",
    "Submission Date": "September 25, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ceftazidime/Avibactam"
    ],
    "Specimen Type(s)": [
        "Isolated colonies of Gram negative bacilli"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2 System",
        "VITEK\u00ae 2 Compact System"
    ],
    "Method(s)/Technology(ies)": [
        "Antimicrobial susceptibility testing (AST)",
        "Minimum inhibitory concentration (MIC) microdilution"
    ],
    "Methodologies": [
        "Automated susceptibility testing",
        "Microdilution methodology"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-GN Ceftazidime/Avibactam automated antimicrobial susceptibility test for Gram negative bacilli",
    "Indications for Use Summary": "For antimicrobial susceptibility testing of Gram negative bacilli as a laboratory aid in determining in vitro susceptibility to ceftazidime/avibactam using VITEK 2 and VITEK 2 Compact Systems",
    "fda_folder": "Microbiology"
}